Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ

International Journal of Gynecological Pathology

Volumn 28, Issue 3, 2009, Pages 272-278

  Rabelo Santos, Silvia Helena ^a   Derchain, Sophie Françoise Mauricette ^b   Villa, Luísa Lina ^c   Costa, Maria Cecília ^c   Sarian, Luis Otávio Zanatta ^b   Westin, Maria Cristina Do Amaral ^b   Kornegay, Janet ^d   Zeferino, Luiz Carlos ^b,e  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d ROCHE MOLECULAR SYSTEMS   (United States)

^e Cidade Universitaria Prof Zeferino Vaz   (Brazil)

Author keywords

Adenocarcinoma in situ; Atypical glandular cells; Cervical carcinoma; Human papillomavirus; PCR

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 69049113910     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318190ed27     Document Type: Article

References (31)

1. Chhieng DC, Gallaspy S, Yang H, et al. Women with atypical glandular cells: a long-term follow-up study in a high-risk population. Am J Clin Pathol 2004;122:575-579 (Pubitemid 39281255)
2. Derchain SF, Rabelo-Santos SH, Sarian LO, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:618-623 (Pubitemid 39592530)
3. Krane JF, Lee KR, Sun D, et al. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004;121:87-92. (Pubitemid 38090158)
4. Lundeen SJ, Horwitz CA, Larson CJ, et al. Abnormal cervicovaginal smears due to endometriosis: a continuing problem. Diagn Cytopathol 2002;26:35-40.
5. Levine L, Lucci JA, Dinh TV. Atypical glandular cells: new Bethesda Terminology and Management Guidelines. Obstet Gynecol Surv 2003;58:399-406. (Pubitemid 36666553)
6. Scheiden R, Wagener C, Knolle U, et al. Atypical glandular cells in conventional cervical smears: incidence and follow-up. BMC Cancer 2004;4:37. (Pubitemid 40180249)
7. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
8. Wright TC Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129 (Pubitemid 34437347)
9. Schoolland M, Allpress S, Sterrett M. Adenocarcinoma of the cervix. Sensitivity of diagnosis by cervical smear and cytologic patterns and pitfalls in 24 cases. Cancer Cytopathol 2002;96:5-12.
10. Simsir A, Hwang S, Cangiarella J, et al. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Cancer 2003;99:323-330 (Pubitemid 38028492)
11. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance: cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-825
12. Andersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical carcinogenesis. Eur J Cancer 2001;37:246-250 (Pubitemid 32144703)
13. Burk RD, Terai M, Gravitt PE, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003;63:7215-7220 (Pubitemid 37413460)
14. Pirog EC, Kleter B, Olgac S, et al. Prevalence of HPV-DNA in different histologic subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-1062 (Pubitemid 30757926)
15. Walboomers JM, Jacobs MV, Bosch FX, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:1-3.
16. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-105 (Pubitemid 36897943)
17. Brestovac B, Harnett GB, Smith DW, et al. Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. J Med Virol 2005;76:106-110 (Pubitemid 40446463)
18. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer 2003;88:63-73. (Pubitemid 36241220)
19. Martens JE, Arends J, Van Der Linden PJQ, et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res 2004;24:771-776 (Pubitemid 38625020)
20. DeMay RM. The Pap smear. In: DeMay RM, ed. The Art and the Science of Cytopathology. 1st ed. Chicago: ASCP Press; 1996:61-185.
21. Gravitt PE, Peyton RJ, Apple RJ, et al. Genotyping of papillomavirus by using L1 consensus PCR products by a single-hybridization reverse line blot detection method. J Clin Microbiol 1998;36:3020-3027
22. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-361
23. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumors. In: World Health Organization. International Histological Classification of Tumors. 2nd ed. Berlin: Springer-Verlag; 1994:36-49.
24. Andersson S, Mints M, Sallstrom J, et al. The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev 2005;29:37-41.
25. Altekruse SF, Lacey JV, Brinton LA, et al. Comparison of human papillomavirus virus genotypes, sexual, and reproductive risk factors of cervical adenocarcinomas and squamous cell carcinoma. Northeastern United States. Am J Obstet Gynecol 2003;188:657-663
26. Munoz N, Bosch FX, De Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527 (Pubitemid 36159887)
27. Xi LF, Toure P, Critchlow CW, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 2003;103:803-809 (Pubitemid 36110238)
28. Franco E, Villa L, Rohan T, et al. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Rev Panam Salud Publica 1999;6:223-233 (Pubitemid 29523611)
29. Meyer T, Arndt R, Beckmann ER, et al. Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia. Int J Gynecol Cancer 2001;11:198-204. (Pubitemid 32622666)
30. Wang SS, Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. Natl Cancer Inst Monogr 2003;31:35-40.
31. Paavonen J, Lehtinen M. Introducing human papillomavirus vaccines-questions remain. Ann Med 2008;40:162-166